US Patent Issued to PRECISIONBIOTIX TECHNOLOGIES on Feb. 25 for "Disinfection of bacteriophages products using supercritical carbon dioxide" (Canadian Inventor)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,232,492, issued on Feb. 25, was assigned to PRECISIONBIOTIX TECHNOLOGIES INC. (Dover, Del.).

"Disinfection of bacteriophages products using supercritical carbon dioxide" was invented by Nancy Tawil (Cantley, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "There is proposed a method for the sterilization of products containing bacteriophages in a manner that will allow the bacteriophages to retain their activity and infectivity. Products containing bacteriophages are exposed to supercritical CO2 under conditions causing little or no damage to structural integrity of the bacteriophages or to the structural properties of biodegradable scaffolds conta...